Soft Tissue, Phase II

A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma

Volunteers
Health Professionals

What is the purpose of this trial?

Randomized, blinded, placebo-controlled, Phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma patients.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Hari Deshpande

hari.deshpande@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Hari Deshpande, MD
Associate Professor of Medicine (Medical Oncology); Clinical Research Team Leader Sarcoma, Medical Oncology; Director Medical Oncology Inpatient Consult Service, Medical Oncology

Sub-Investigators

Last Updated
12/05/2024
Study HIC
#2000038416